Profiles for companies starting with 'e'
✉ Email this page to a colleague
Drugs and US Patents for e
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | DISCN | Yes | No | 7,851,482 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Eirgen | RAYALDEE | calcifediol | CAPSULE, EXTENDED RELEASE;ORAL | 208010-001 | Jun 17, 2016 | RX | Yes | Yes | 8,207,149 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,090,562 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Eskayef | PREGABALIN | pregabalin | CAPSULE;ORAL | 212988-001 | Mar 8, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |